Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Berkshire Hathaway Inc. (NYSE:BRK.B), Eagle Rock Energy Partners, L.P. (NASDAQ:EROC), Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP), Dynavax Technologies Corporation (NASDAQ:DVAX)
Berkshire Hathaway Inc. (NYSE:BRK.B) managed to keep its gain at 0.03% on below -normal volume of 1.94M shares. The stock settled at $118.04 after floating in a range of $117.75 to $118.56. Its latest price has reached market capitalization of $291.57 billion. Its 52-week range has been $88.11 to $119.30. Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities.
For How Long BRK.B will fight for Profitability? Read This Trend Analysis report
Eagle Rock Energy Partners, L.P. (NASDAQ:EROC) traded down on a volume of 3.43 million, higher than its standard daily volume. Shares have dropped -4.17% to $5.74. Over the last twelve months, the stock has lost-33.64% and faced a worst price of $26. Eagle Rock Energy Partners, L.P. (Eagle Rock) is a limited partnership engaged in the business of gathering, compressing, treating, processing and transporting natural gas; fractionating and transporting natural gas liquids (NGLs); crude oil logistics and marketing; natural gas marketing and trading, known as Midstream Business, and developing and producing interests in oil and natural gas properties, known as Upstream Business.
Has EROC Found The Bottom And Ready To Gain Momentum? Find Out Here
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) settled 15.94% higher at $15.06 on above-normal volume of 1.94M shares during the last trading day. The stock has its 12-month high at $16.60 and 52-week low price was $3.72. It traded in a range of $13.51 to $16.60 during the last trading day. Oramed Pharmaceuticals Inc. is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides.
Why Should Investors Buy ORMP After the Recent Fall? Just Go Here and Find Out
In the last trading session, Dynavax Technologies Corporation (NASDAQ:DVAX) was up on low volume, trading at a volume of 3.44M shares versus its average daily volume of 5.54 million shares. At $2, the stock has attained market capitalization of $525.25 million. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines.
Will DVAX Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)